The results showed a similarly significantly lower DNASE1L3 expression in cervical cancer samples when compared to normal cervical samples (Figure 7d), which suggested that the dysregulation of DNASE1L3 may play a role in the development and progression of cervical cancer. This evidence concerns the gene DNASE1L3 and cervical carcinoma.